A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain

@article{Goldberg2007AMO,
  title={A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain},
  author={Robert J. Goldberg and Joel D Katz},
  journal={Pain},
  year={2007},
  volume={129},
  pages={210-223}
}
Abstract Between 40% and 60% of Americans use complementary and alternative medicine to manage medical conditions, prevent disease, and promote health and well‐being. Omega‐3 polyunsaturated fatty acids (ω‐3 PUFAs) have been used to treat joint pain associated with several inflammatory conditions. We conducted a meta‐analysis of 17 randomized, controlled trials assessing the pain relieving effects of ω‐3 PUFAs in patients with rheumatoid arthritis or joint pain secondary to inflammatory bowel… Expand

Paper Mentions

Interventional Clinical Trial
This study is single site, double-blind, randomized, cross-over study designed to compare the effects of flax oil and fish oil supplementation on the oxylipin profile in healthy males… Expand
ConditionsHealthy
InterventionDietary Supplement
Effect of ω-3 polyunsaturated fatty acids on arthritic pain: A systematic review.
OBJECTIVES Pain is a significant problem in rheumatoid arthritis (RA) and is associated with prostaglandins derived from the ω-6 polyunsaturated fatty acid (PUFA) arachidonic acid. The ω-3 PUFAsExpand
Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis.
TLDR
This meta-analysis suggests that the use of omega-3 PUFAs at dosages >2.7 g/day for >3 months reduces NSAID consumption by RA patients, and further studies are needed to explore the clinical and NSAID-sparing effects of Omega-3PUFAs in RA. Expand
Intake of ω-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: A systematic review and meta-analysis.
OBJECTIVES Rheumatoid arthritis (RA) is a chronic, autoimmune inflammatory disease of multiple joints that puts the patient at high risk for developing cardiovascular diseases (CVDs). The aim of theExpand
Administration of Omega-3 Fatty Acids Reduces Positive Tender Point Count in Chronic Musculoskeletal Pain Patients
TLDR
The supplement had no effect on blood lipids and questionnaires indicatedno effect on mood, sleep problems and other pain indicators, and the present results encourage clinical trials in larger samples to compare the effects of different daily amounts and treatment durations of n-3 supplementation. Expand
Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain
TLDR
High-dose n − 3 PUFA supplementation is feasible and well tolerated when administered with AIs, and additional studies are needed to evaluate efficacy in prevention of joint symptoms. Expand
Beneficial effect of n-3 polyunsaturated fatty acids on inflammation and analgesic use in psoriatic arthritis: a randomized, double blind, placebo-controlled trial
TLDR
The n-3 PUFA-supplemented group showed improvement in outcome measures for disease activity, although the difference between the groups was not statistically significant. Expand
The impact of fish oil supplementation in patients with rheumatoid arthritis
TLDR
The use of omega-3 PUFAs at dosages of >2.7 g/day for more than three months can be effective at decreasing NSAID use in rheumatoid arthritis patients. Expand
omega-3 polyunsaturated fatty acids from pharmaceutical-grade fish oil supplements results in pain reduction and functional improvement in patients with neuropathic pain
~ e literature of the past twenty years contains numerous studies and clinical investigations that highlight the critical role played by omega-3 polyunsaturated fatty acids (PUFAs) in human healthExpand
Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.
  • D. Hershman, J. Unger, +10 authors C. Moinpour
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2015
TLDR
A substantial and sustained improvement in AI arthralgia is found for both O3-FAs and placebo for both women with early-stage breast cancer and no between-group differences were seen for HDL, LDL, or C-reactive protein. Expand
Do omega-6 and trans fatty acids play a role in complex regional pain syndrome? A pilot study.
TLDR
These pilot data suggest that elevated n- 6 HUFA and trans FA may play a role in CRPS pathogenesis and more research is needed to explore the clinical significance of low n-6 and transFA diets with or without concurrent n-3 HU FA supplementation, for the management of CRPS. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 99 REFERENCES
EFFECTS OF MANIPULATION OF DIETARY FATTY ACIDS ON CLINICAL MANIFESTATIONS OF RHEUMATOID ARTHRITIS
TLDR
On follow-up evaluation 1-2 months after stopping the diet, the experimental group had deteriorated significantly in patient and physician global evaluation of disease activity, pain assessment, and number of tender joints. Expand
Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects
TLDR
This double-blind, placebo-controlled study in RA patients did not show superior clinical benefit of daily nutrient supplementation with EPA, GLA and micronutrients at the doses tested as compared to placebo. Expand
The effects of dietary supplementation with n‐3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial
TLDR
Dietary supplementation with n‐3 PUFA in patients with rheumatoid arthritis improved two out of six patient reported disease parameters, and further studies are needed to clarify the more precise role of n‐2 polyunsaturated fatty acids in the treatment of rhearatoid arthritis. Expand
Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis.
TLDR
N-3 fatty acids in fish and fish oil can inhibit production of both eicosanoid and cytokine inflammatory mediators and therefore, have the potential to modify rheumatoid arthritis pathology. Expand
Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates.
TLDR
Patients taking dietary supplements of fish oil exhibit improvements in clinical parameters of disease activity from baseline, including the number of tender joints, and these improvements are associated with significant decreases in levels of IL-1 beta from baseline. Expand
Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study.
TLDR
Daily supplementation with 2.6 gm of omega 3 results in significant clinical benefit and may reduce the need for concomitant antirheumatic medication. Expand
Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis
TLDR
A diet low in arachidonic acid ameliorates clinical signs of inflammation in patients with RA and augments the beneficial effect of fish oil supplementation. Expand
Dietary omega-3 fatty acid supplementation and naproxen treatment in patients with rheumatoid arthritis.
TLDR
There was a significant deterioration for most of the variables measured, however, for duration of morning stiffness the deterioration was significantly less pronounced in Group 3 compared with Group 1, which might be ascribed to the dietary omega-3 fatty acid supplementation. Expand
Diet and rheumatoid arthritis: a review of the literature.
TLDR
Dietary manipulation provides a means by which patients can a regain a sense of control over their disease and Randomized controlled trials indicate that dietary supplementation with n-3 fatty acids provides modest symptomatic benefit in groups of patients with rheumatoid arthritis. Expand
Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis.
TLDR
It is suggested that fish oil supplementation that delivers (n-3) fatty acids at a dose of 40 mg/kg body weight/day, with dietary dietary fatty acid intake < 10 g/day in the background diet, results in substantial cellular incorporation of (n)-3 fatty acids and improvements in clinical status in patients with RA. Expand
...
1
2
3
4
5
...